ANI Pharmaceuticals Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
301.00
28,747.00
15,375.00
3,934.00
1,076.00
15,494
Depreciation, Depletion & Amortization
1,110.00
3,878.00
6,900.00
22,343.00
27,928.00
33,742
Other Funds
-
784.00
360.00
617.00
-
15,478
Funds from Operations
6,082.00
22,148.00
31,125.00
37,399.00
45,071.00
59,534
Changes in Working Capital
11,566.00
115.00
13,861.00
9,927.00
5,652.00
5,968
Net Operating Cash Flow
5,484.00
22,033.00
17,264.00
27,472.00
39,419.00
65,502
Capital Expenditures
191.00
35,754.00
32,683.00
149,060.00
107,993.00
Sale of Fixed Assets & Businesses
18,198.00
-
-
-
-
Purchase/Sale of Investments
-
-
-
5,002.00
-
Net Investing Cash Flow
20,267.00
35,754.00
32,683.00
154,062.00
107,993.00
Issuance/Reduction of Debt, Net
4,065.00
138,243.00
-
294.00
72,263.00
Net Financing Cash Flow
3,689.00
171,653.00
1,066.00
729.00
72,357.00
Net Change in Cash
11,094.00
157,932.00
14,353.00
127,319.00
3,783.00
Free Cash Flow
5,675.00
20,913.00
15,081.00
22,906.00
29,050.00
Deferred Taxes & Investment Tax Credit
-
14,459.00
1,877.00
8,911.00
3,560.00
5,180
Other Sources
2,260.00
-
-
-
-
Change in Capital Stock
376.00
32,626.00
706.00
1,052.00
94.00
About ANI Pharmaceuticals
View Profile
